IFN-alpha Subtype Detection via Segmented PCR and Molecular Beacons
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current tools lack sensitivity and specificity to measure individual interferon (IFN) subtypes, hindering the understanding of their roles in diseases and limiting therapeutic approaches for conditions like systemic lupus erythematosus, multiple sclerosis, and hepatitis C.
Innovation Solution
A highly sensitive and specific quantitative real-time PCR assay using molecular beacons and locked nucleic acids (LNA) to differentiate between IFN subtypes, allowing for the simultaneous amplification and detection of all IFN subtypes under the same reaction conditions, with primer/probe sets targeting specific coding sequences to avoid spurious detection of degraded mRNA.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional assays are used to detect interferon subtypes, then the assay can be performed with simple equipment, but the sensitivity and specificity are insufficient to distinguish between highly homologous IFN-alpha subtypes
Solution Approach 1:
The assay divides the detection of multiple IFN-alpha subtypes into separate, specific reactions using subtype-specific primer pairs. Each primer pair is designed to amplify a unique region of the IFN-alpha gene, allowing individual subtypes to be detected and distinguished from one another through sequence analysis of the amplification products.
Solution Approach 2:
The patent employs molecular beacons as intermediary probes that specifically bind to amplified IFN-alpha subtype sequences. These beacons contain fluorescent dyes and quenchers that enable detection of the amplified products, serving as intermediaries between the primer pairs and the final detection signal, thereby achieving high specificity without requiring complex equipment.
2Measurement precision
If the assay targets 3' untranslated regions of mRNA, then easier priming is achieved, but spurious detection of degraded mRNA occurs
Solution Approach 1:
The patent extracts and targets the coding sequence region of the IFN-alpha gene for amplification, specifically avoiding the 3' untranslated regions that are prone to degradation. By focusing on the coding sequence, the assay eliminates spurious detection of degraded mRNA while maintaining ease of primer design through the use of well-defined, conserved coding regions that are easy to identify and amplify.
3Adaptability or versatility
If multiple IFN subtypes are detected simultaneously, then comprehensive monitoring is achieved, but cross-reactivity between highly homologous subtypes occurs
Solution Approach 1:
The assay uses multiple separate primer pairs, each specific to a particular IFN-alpha subtype. This segmentation allows simultaneous detection of multiple subtypes in a single reaction mixture while preventing cross-reactivity, as each primer pair is designed to amplify a unique region that is distinct for its target subtype.
Solution Approach 2:
The patent applies local quality by designing primer pairs that target specific, unique regions within the IFN-alpha coding sequence for each subtype. This localized targeting ensures that each primer pair only amplifies its intended subtype, maintaining high specificity even when multiple subtypes are present in the same sample.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise monitoring of IFN subtype expression patterns associated with diseases, facilitating personalized medicine and improving therapeutic strategies by accurately detecting as few as 1-10 copies of IFN-alpha subtype per reaction with high specificity.
Implementation Method 1
The invention provides nucleic acid amplification techniques for differentiating between highly related nucleic acid molecules. In current embodiments, polymerase chain reaction (PCR) and novel probe/primer pairs are used to differentiate between IFN subtypes.
Implementation Method 2
The assay exploits two modifications of probe-based RT-PCR: molecular beacons (MB) and locked nucleic acids (LNA). The primer/probe sets, associated methods using them... can be used to establish patterns of IFN subtype expression
Data Source
AI summary
The invention provides highly sensitive, specific and efficient quantitative real-time PCR compositions, methods and assay kits to detect at least one IFN subtype and/or IFN subtype allotypic variants. Primer/probe sets complementary to the coding sequence of an IFN subtype of interest avoid spurious detection of degraded mRNA and enhances the correlation between the IFN subtype that is measured by the assays of the invention and the protein that is actually expressed. The invention also provides methods for designing primers and methods of using the compositions and assay kits. The compositions, kits, and methods of the invention may be used, for example, to monitor vaccine efficacy, autoimmune disease, chronic infections, or tumor therapy.